Yan Yan

Yan Yan

Auto-generated profile, based on publicly available information

Yan Yan

Department of Clinical Laboratory, The Second Hospital of Dalian Medical University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
JJJie Jiang
Jie Jiang
YYYan Yan
Yan Yan
CYChunhui Yang
Chunhui Yang
HCHong Cai
Hong Cai
Immunogenic cell death (ICD) is a promising cancer therapy where dying tumor cells release damage-associated molecular patterns (DAMPs) to activate immune responses. Recent research highlights the critical role of metabolic reprogramming in tumor cells, including the Warburg effect, oxidative stress, and lipid metabolism, in modulating ICD and shaping the immune microenvironment. These metabolic changes enhance immune activation, making tumors more susceptible to immune surveillance. This review explores the molecular mechanisms linking ICD and metabolism, including mitochondrial oxidative stress, endoplasmic reticulum (ER) stress, and ferroptosis. It also discusses innovative therapeutic strategies, such as personalized combination therapies, metabolic inhibitors, and targeted delivery systems, to improve ICD efficacy. The future of cancer immunotherapy lies in integrating metabolic reprogramming and immune activation to overcome tumor immune evasion, with multi-omics approaches and microbiome modulation offering new avenues for enhanced treatment outcomes.

10 September 2026 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
HWHuanle Wang
Huanle Wang
YZYinan Zhang
Yinan Zhang
SJSufen Jiang
Sufen Jiang
XLXiaojiang Li
Xiaojiang Li
YZYixin Zheng
Yixin Zheng
YYYan Yan
Yan Yan
Potassium (K + ) channels sustain immune-cell activation by coupling K + flux to membrane potential, Ca 2+ signaling, migration, and metabolic adaptation. In solid tumors, however, extracellular K + accumulation, adenosine, hypoxia, acidosis, oxidative stress, and lipid stress can disrupt ionic homeostasis and channel function. Here, we define an ionic checkpoint as a context-dependent regulatory state in which K + gradients, channel gating and trafficking, membrane potential, and subcellular channel localization determine whether immune cells cross the electrophysiological thresholds required for Ca 2+ signaling and effector function. We synthesize evidence across adaptive and innate immunity, emphasizing Kv1.3 and KCa3.1 in T- and natural killer-cell responses and dendritic-cell migration, and Kir and K2P channels in myeloid and NK-cell programs. We further examine plasma-membrane–mitochondrial channel crosstalk, redox regulation, and spatial and temporal heterogeneity in the tumor immune microenvironment. Because the same channel may support lymphocyte function while sustaining tumor-cell survival or immunosuppressive myeloid states, neither universal activation nor universal inhibition is appropriate. Direct channel targeting is constrained by cell and organelle selectivity, whereas upstream tumor-microenvironment-directed strategies, particularly adenosine-axis interventions, are clinically more advanced but have not yet established direct restoration of K + channel-supported immune function. Translation will require functional and spatial biomarkers, precision patient stratification, and cell- or organelle-selective delivery.

1 October 2020
Verified
Journal Article
Closed access
YWYing Wang
Ying Wang
YYYan Yan
Yan Yan
ZWZhong-Li Wang
Zhong-Li Wang